Company Overview of Fidia Farmaceutici s.p.a.
Fidia Farmaceutici s.p.a. researches, develops, manufactures, markets, and sells medicinal products, medical devices, and dietary supplements primarily based on hyaluronic acid and its derivatives. The company’s primary business areas include treatment and management of joint care/musculoskeletal disorders, including osteoarthritis, and advanced wound care/dermo-aesthetics. The company offers dietary supplements, hyaluronic acid sodium salts, diclofenac sodium salts, gingival gels, hyaluronic acid sodium salt for intra-dermal administration, auto cross-linked hyaluronic acid for intra-dermal administration, vaginal bioequilibrant gels, topical gels, cream-impregnated gauze pads for topical u...
Via Ponte della Fabbrica 3/A
Abano Terme, PD 35031
Founded in 1946
Key Executives for Fidia Farmaceutici s.p.a.
Compensation as of Fiscal Year 2014.
Fidia Farmaceutici s.p.a. Key Developments
Fidia Opens Subsidiary in Germany
Nov 18 13
Fidia Farmaceutici has recently announced the decision to open a new subsidiary in Germany. The new branch will be located in Monheim am Rhein. Fidia Farmaceutici markets its products in over 100 countries globally through licensing agreements, distribution and partnerships. It has subsidiaries located in USA and Kazakhstan, and is planning to launch hyaluronic acid-derived products such as Hymovis and Hyalone on the German market.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries